nobiletin has been researched along with ng-nitroarginine methyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kukongviriyapan, U; Maneesai, P; Pakdeechote, P; Potue, P; Prachaney, P; Wunpathe, C | 1 |
| Hanaguri, J; Harino, S; Kushiyama, A; Miyata, Y; Nagaoka, T; Ohno, A; Takase, K; Watanabe, M; Yamagami, S; Yokota, H | 1 |
2 other study(ies) available for nobiletin and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Nobiletin alleviates vascular alterations through modulation of Nrf-2/HO-1 and MMP pathways in l-NAME induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Blood Vessels; Collagen; Flavones; Heme Oxygenase (Decyclizing); Humans; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; NF-E2-Related Factor 2; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Signal Transduction | 2019 |
Dilation of porcine retinal arterioles to nobiletin, a polymethoxyflavonoid: Roles of nitric oxide and voltage-dependent potassium channel.
Topics: Animals; Arterioles; Dilatation; Endothelium, Vascular; Enzyme Inhibitors; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Swine; Vasodilation | 2023 |